5.1 Study withdrawal due to adverse events |
3 |
72 |
Risk Ratio (M‐H, Random, 95% CI) |
2.09 [0.26, 16.82] |
5.1.1 Fluoxetine 20 mg daily |
3 |
72 |
Risk Ratio (M‐H, Random, 95% CI) |
2.09 [0.26, 16.82] |
5.2 Adverse events |
4 |
140 |
Risk Ratio (M‐H, Random, 95% CI) |
2.50 [1.29, 4.86] |
5.2.1 Fluoxetine 20 mg daily |
2 |
57 |
Risk Ratio (M‐H, Random, 95% CI) |
9.32 [1.88, 46.26] |
5.2.2 Fluoxetine 40 mg daily |
1 |
23 |
Risk Ratio (M‐H, Random, 95% CI) |
2.29 [0.55, 9.49] |
5.2.3 Fluoxetine 90 mg daily |
1 |
60 |
Risk Ratio (M‐H, Random, 95% CI) |
1.78 [0.76, 4.17] |
5.3 Intravaginal ejaculatory latency time |
5 |
149 |
Mean Difference (IV, Random, 95% CI) |
2.46 [1.52, 3.39] |
5.3.1 Fluoxetine 20 mg daily |
3 |
66 |
Mean Difference (IV, Random, 95% CI) |
2.87 [1.26, 4.48] |
5.3.2 Fluoxetine 40 mg daily |
1 |
23 |
Mean Difference (IV, Random, 95% CI) |
‐0.54 [‐3.57, 2.49] |
5.3.3 Fluoxetine 90 mg daily |
1 |
60 |
Mean Difference (IV, Random, 95% CI) |
2.72 [1.83, 3.61] |
5.4 Depression |
1 |
14 |
Risk Ratio (M‐H, Random, 95% CI) |
2.00 [0.23, 17.34] |
5.4.1 Fluoxetine 20 mg daily |
1 |
14 |
Risk Ratio (M‐H, Random, 95% CI) |
2.00 [0.23, 17.34] |